Registry for patients having TIF2.0 or cTIF procedure
Part of Digestive system clinical trials.
This registry gathers information on patients who undergo TIF2.0 or cTIF procedures to treat gastroesophageal reflux disease (GERD). By joining, you help doctors learn more about these procedures and their outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled to have a TIF2.0 or cTIF procedure for heartburn or acid reflux.
- You can understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry, meaning it collects health information to better understand people who have a TIPS procedure for high pressure in the liver’s blood vessels. It may help doctors improve how TIPS is used and monitored over time.
This is an observational study (no experimental treatment) that follows people who choose a specific procedure called transoral incisionless fundoplication (TIF) with the EsophyX device for long-term acid reflux. It aims to track outcomes for up to 5 years at San Raffaele Hospital.
This study keeps information on people who already had a TIF procedure at Indiana University. It helps researchers learn from past treatments and may improve future care.
This trial looks at outcomes after a procedure called TIF to help control reflux after Barrett’s esophagus has been fully treated with endoscopic ablation. You might benefit if you still have abnormal acid reflux and want an option other than lifelong acid-suppressing medication.
This trial tests a newer, less invasive surgical procedure called TIF (Transoral Incisional Fundoplication) for patients with severe acid reflux and regurgitation that hasn't improved with high-dose medications. The procedure is done through the mouth rather than the abdomen, and researchers will follow patients for 5 years to see if it works and is safe in Asian populations.
This registry study follows people with long-term acid reflux (GERD) who get the RefluxStop treatment. It mainly collects real-world safety and performance information to see how well the device helps over time.
Hear when a new Gastro -Oesophagal Reflux trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.